Nifty
Sensex
:
:
11354.25
37808.91
-102.65 (-0.90%)
-355.70 (-0.93%)

Pharmaceuticals & Drugs

Rating :
43/99

BSE: 540222 | NSE: LAURUSLABS

373.90
-11.00 (-2.86%)
25-Mar-2019 | 3:57PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  384.90
  •  384.90
  •  369.10
  •  384.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  108441
  •  405.46
  •  520.00
  •  321.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,105.27
  • 42.91
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,082.12
  • 0.39%
  • 2.72

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 33.50%
  • 5.36%
  • 11.93%
  • FII
  • DII
  • Others
  • 0.11%
  • 37.03%
  • 12.07%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 12.13
  • 4.97

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 15.21
  • 2.68

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 11.51
  • 7.71

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 31.57

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 3.74

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 14.53

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
529.46
478.93
10.55%
588.28
538.61
9.22%
539.02
491.22
9.73%
560.24
0.00
0.00
Expenses
441.74
391.58
12.81%
512.56
426.04
20.31%
458.46
394.71
16.15%
443.36
0.00
0.00
EBITDA
87.71
87.35
0.41%
75.73
112.57
-32.73%
80.55
96.51
-16.54%
116.88
0.00
0.00
EBIDTM
16.57%
18.24%
12.87%
20.90%
14.94%
19.65%
20.86%
0.00%
Other Income
1.42
9.94
-85.71%
10.53
6.63
58.82%
2.59
7.54
-65.65%
5.08
0.00
0.00
Interest
23.65
17.76
33.16%
24.64
19.52
26.23%
22.32
19.10
16.86%
23.26
0.00
0.00
Depreciation
42.71
30.98
37.86%
39.82
30.08
32.38%
38.19
29.79
28.20%
34.61
0.00
0.00
PBT
22.77
48.55
-53.10%
21.79
69.60
-68.69%
22.62
55.17
-59.00%
64.09
0.00
0.00
Tax
4.95
13.68
-63.82%
5.58
20.84
-73.22%
6.07
16.27
-62.69%
19.01
0.00
0.00
PAT
17.82
34.87
-48.90%
16.21
48.76
-66.76%
16.56
38.91
-57.44%
45.08
0.00
0.00
PATM
3.37%
7.28%
2.76%
9.05%
3.07%
7.92%
8.05%
0.00%
EPS
1.67
3.28
-49.09%
1.52
4.60
-66.96%
1.56
3.68
-57.61%
4.25
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
2,217.00
2,056.17
1,904.65
1,777.58
1,326.59
1,159.72
Net Sales Growth
46.94%
7.96%
7.15%
34.00%
14.39%
 
Cost Of Goods Sold
1,184.65
1,056.02
989.29
1,000.15
821.27
720.43
Gross Profit
1,032.35
1,000.15
915.36
777.43
505.32
439.29
GP Margin
46.57%
48.64%
48.06%
43.74%
38.09%
37.88%
Total Expenditure
1,856.12
1,642.85
1,497.01
1,415.38
1,131.46
956.09
Power & Fuel Cost
-
94.21
66.27
57.95
49.86
35.03
% Of Sales
-
4.58%
3.48%
3.26%
3.76%
3.02%
Employee Cost
-
238.14
204.73
175.46
131.38
103.25
% Of Sales
-
11.58%
10.75%
9.87%
9.90%
8.90%
Manufacturing Exp.
-
150.78
139.47
106.97
80.61
47.96
% Of Sales
-
7.33%
7.32%
6.02%
6.08%
4.14%
General & Admin Exp.
-
73.17
65.42
49.09
28.39
27.30
% Of Sales
-
3.56%
3.43%
2.76%
2.14%
2.35%
Selling & Distn. Exp.
-
24.09
22.65
16.49
12.46
12.54
% Of Sales
-
1.17%
1.19%
0.93%
0.94%
1.08%
Miscellaneous Exp.
-
6.44
9.18
9.27
7.49
9.58
% Of Sales
-
0.31%
0.48%
0.52%
0.56%
0.83%
EBITDA
360.87
413.32
407.64
362.20
195.13
203.63
EBITDA Margin
16.28%
20.10%
21.40%
20.38%
14.71%
17.56%
Other Income
19.62
29.19
33.44
4.36
34.07
8.82
Interest
93.87
79.64
99.90
111.11
101.11
58.71
Depreciation
155.33
125.45
105.98
86.41
61.53
32.88
PBT
131.27
237.42
235.19
169.04
66.57
120.86
Tax
35.61
69.81
43.86
34.90
-1.55
23.64
Tax Rate
27.13%
29.40%
18.65%
20.65%
-2.33%
19.56%
PAT
95.67
167.61
191.33
134.14
68.12
97.22
PAT before Minority Interest
95.67
167.61
191.33
134.14
68.12
97.22
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
4.32%
8.15%
10.05%
7.55%
5.13%
8.38%
PAT Growth
-21.93%
-12.40%
42.63%
96.92%
-29.93%
 
Unadjusted EPS
9.00
15.83
20.78
21.37
44.27
63.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
1,482.64
1,330.45
856.80
722.10
358.42
Share Capital
106.03
105.76
82.38
82.13
77.84
Total Reserves
1,370.75
1,218.84
771.47
637.03
277.22
Non-Current Liabilities
174.30
132.34
428.11
363.73
203.92
Secured Loans
141.66
124.56
353.61
303.68
188.17
Unsecured Loans
0.00
0.00
106.13
0.00
0.00
Long Term Provisions
20.84
14.59
6.77
5.13
3.93
Current Liabilities
1,306.89
1,120.75
883.75
802.49
710.87
Trade Payables
312.33
263.10
247.61
230.81
227.47
Other Current Liabilities
231.26
199.11
141.05
133.34
164.25
Short Term Borrowings
758.52
644.17
481.42
431.63
312.18
Short Term Provisions
4.78
14.37
13.66
6.70
6.97
Total Liabilities
2,963.83
2,583.54
2,168.66
1,888.32
1,273.21
Net Block
1,480.80
1,229.93
1,021.03
801.01
499.27
Gross Block
1,793.75
1,418.58
1,106.33
986.17
623.32
Accumulated Depreciation
312.95
188.65
85.30
185.16
124.04
Non Current Assets
1,716.23
1,443.71
1,165.92
1,024.41
696.70
Capital Work in Progress
163.18
143.26
69.60
109.67
116.10
Non Current Investment
3.40
3.40
7.04
7.45
0.00
Long Term Loans & Adv.
28.21
25.95
29.22
93.94
68.50
Other Non Current Assets
40.65
41.17
39.03
12.34
12.82
Current Assets
1,247.59
1,139.82
1,002.73
862.27
574.81
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
584.78
509.05
487.09
475.50
328.10
Sundry Debtors
570.59
567.61
444.86
285.07
194.88
Cash & Bank
3.06
4.09
28.77
58.88
23.20
Other Current Assets
89.16
34.07
18.14
20.07
28.64
Short Term Loans & Adv.
58.63
25.01
23.86
22.75
19.80
Net Current Assets
-59.30
19.07
118.98
59.78
-136.06
Total Assets
2,963.82
2,583.53
2,168.65
1,888.32
1,273.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
342.49
331.99
181.97
-64.71
121.23
PBT
237.42
235.19
169.04
66.57
120.86
Adjustment
223.95
199.38
200.57
136.26
83.06
Changes in Working Capital
-56.96
-52.45
-154.37
-250.72
-59.27
Cash after chg. in Working capital
404.41
382.12
215.23
-47.89
144.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-61.91
-50.13
-33.26
-16.82
-23.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-384.15
-288.67
-312.20
-396.95
-311.82
Net Fixed Assets
-394.43
-354.15
-76.75
-353.86
Net Investments
-1.22
-24.40
-7.01
-18.65
Others
11.50
89.88
-228.44
-24.44
Cash from Financing Activity
42.24
-53.61
103.32
486.08
203.03
Net Cash Inflow / Outflow
0.59
-10.30
-26.91
24.42
12.44
Opening Cash & Equivalents
2.42
12.81
39.53
15.11
2.67
Closing Cash & Equivalent
3.00
2.42
12.81
39.53
15.11

Financial Ratios

Standalone /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
139.28
125.25
499.30
419.61
189.14
ROA
6.04%
8.05%
6.61%
4.31%
7.64%
ROE
11.97%
18.12%
18.65%
14.47%
33.42%
ROCE
13.68%
16.52%
16.35%
13.74%
19.96%
Fixed Asset Turnover
1.29
1.53
1.73
1.66
1.87
Receivable days
100.40
95.66
73.56
65.47
61.02
Inventory Days
96.48
94.12
97.00
109.61
102.73
Payable days
61.13
59.14
58.52
69.29
86.77
Cash Conversion Cycle
135.75
130.64
112.05
105.79
76.98
Total Debt/Equity
0.66
0.64
1.20
1.14
1.54
Interest Cover
3.98
3.35
2.52
1.66
3.06

News Update:


  • Amansa Holdings buys 33 lakh shares in Laurus Labs
    15th Mar 2019, 11:10 AM

    FIL Capital Management has offloaded 61.19 lakh shares in the company at Rs 351.15 per share

    Read More
  • Laurus Labs receives approvals from USFDA
    11th Mar 2019, 15:17 PM

    The products will be commercialized from Laurus' manufacturing site located at Atchutapuram, Visakhapatnam

    Read More
  • Laurus Labs gets approval from USFDA for TLD
    4th Feb 2019, 09:01 AM

    The company expects to commercialise this important medicine in the access markets

    Read More
  • Laurus Labs gets EIR from USFDA for unit 6 in Andhra Pradesh
    4th Feb 2019, 08:51 AM

    The manufacturing unit 6 was inspected by the regulatory agency in the month of November 2018

    Read More
  • Laurus Labs - Quarterly Results
    31st Jan 2019, 17:23 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.